IL6 and interstitial lung disease: Because colchicine can attenuate cytokine storm observed in patients with Coronavirus infection by exerting anti-inflammatory effects through the same pathway as that noted in anti-IL-6, thus, if the ILD patients concurrent with virus infection having the colchicine use, these groups with comorbidities may continue to receive the colchicine use in the Coronavirus era (50).